...
首页> 外文期刊>PACE: Pacing and clinical electrophysiology >Radiofrequency ablation of accessory pathways in children and congenital heart disease patients: impact of a nonfluoroscopic navigation system.
【24h】

Radiofrequency ablation of accessory pathways in children and congenital heart disease patients: impact of a nonfluoroscopic navigation system.

机译:儿童和先天性心脏病患者辅助途径的射频消融:非荧光镜导航系统的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: We sought to assess the impact of routine use of a nonfluoroscopic navigation system in the procedural aspects of radiofrequency ablation of accessory pathways (APs) in pediatric and congenital heart disease (CHD) patients and the reduction of fluoroscopy in different pathway locations. METHODS: This was a retrospective review of 192 patients, divided in two groups: group A (76 patients, fluoroscopic only ablation) and group B (116 patients, combined use of fluoroscopy and a nonfluoroscopic system (NavX). Comparison of procedural aspects (procedure time, fluoroscopy time, success, complications, and recurrences) was performed. RESULTS: The two groups were comparable in terms of age, AP location, and presence of CHD. The mean age was 11.34 +/- 4.65 years in group A versus 10.91 +/- 3.68 years in group B. The procedure duration was significantly shorter in group B than in group A (177.06 +/- 62.18 vs 242.45 +/- 99.07) (P < 0.001). There was a significant reduction in the fluoroscopy time in group B compared to group A (8.27 +/- 8.23 vs 39.77 +/- 32.65 minutes) (P < 0.001). The difference between the two groups was statistically significant in all categories of APs. The success rate was 97.4% in group A and 96.6% in group B. There were no complications directly related to the use of the nonfluoroscopic system. There was no difference in the recurrence rate. CONCLUSIONS: The use of a nonfluoroscopic system for catheter navigation resulted in significant reduction of total procedure and fluoroscopy time during catheter ablation of APs in pediatric and CHD patients, regardless of the location of the pathway, without a compromise in safety and efficacy.
机译:背景:我们试图评估非荧光镜导航系统的常规使用在小儿和先天性心脏病(CHD)患者射频消融辅助通路(AP)的程序方面以及在不同通路位置减少荧光透视的影响。方法:这是对192例患者的回顾性回顾,分为两组:A组(76例,仅使用透视检查消融)和B组(116例,使用透视和非透视检查系统(NavX)的联合使用。结果:两组在年龄,AP位置和冠心病的存在方面具有可比性,A组的平均年龄为11.34 +/- 4.65岁,而A组与B组的手术时间为10.91 +/- 3.68年。B组的手术时间明显短于A组(177.06 +/- 62.18 vs 242.45 +/- 99.07)(P <0.001)。 B组的时间比A组的时间(8.27 +/- 8.23 vs 39.77 +/- 32.65分钟)(P <0.001)。两组之间的差异在所有类别的AP上均具有统计学意义,成功率为97.4%。 A组和B组为96.6%。没有并发症直接相关。 o使用非荧光镜系统。复发率没有差异。结论:使用非荧光镜系统进行导管导航可显着减少儿科和冠心病患者的AP导管消融过程中的总程序和透视时间,而无论该通路的位置如何,都不会影响安全性和有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号